Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lung cancer: some progress, but still a lot more to do.

Literature DB >> 31777378

Lung cancer: some progress, but still a lot more to do.

Abstract

Entities: Disease

Mesh：

Year: 2019 PMID： 31777378 DOI： 10.1016/S0140-6736(19)32795-3

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

Review 1. Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors: Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal: Transl Lung Cancer Res Date: 2021-06

2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.

Authors: Xiuao Zhang; Zhengcun Wu; Kaili Ma
Journal: BMC Cancer Date: 2022-04-14 Impact factor: 4.430

Review 3. Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review.

Authors: Na Li; Huanrui Zheng; Bin Zheng; Chaoxin Chen; Hongfu Cai; Maobai Liu
Journal: Cancer Manag Res Date: 2020-06-12 Impact factor: 3.989

Review 4. Microbiome dysbiosis in lung cancer: from composition to therapy.

Authors: Ning-Ning Liu; Qiang Ma; Yang Ge; Cheng-Xiang Yi; Lu-Qi Wei; Jing-Cong Tan; Qiao Chu; Jing-Quan Li; Peng Zhang; Hui Wang
Journal: NPJ Precis Oncol Date: 2020-12-10

5. Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study.

Authors: Yunfei Ma; Guangda Li; Xiaoxiao Li; Yu Gao; Tongjing Ding; Guowang Yang; Yi Zhang; Jiayun Nian; Mingwei Yu; Xiaomin Wang
Journal: J Cancer Date: 2021-03-19 Impact factor: 4.207

Lung cancer: some progress, but still a lot more to do.

Review 1. Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

2. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.

Review 3. Economic Evaluations of Immune Checkpoint Inhibitors for Patients with Non-Small Cell Lung Cancer: A Systematic Review.

Review 4. Microbiome dysbiosis in lung cancer: from composition to therapy.

5. Clinical characteristics and prognostic analysis of Lung Cancer patients with Hypercoagulability: A single-center, retrospective, real-world study.

6. miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.

7. MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer.

8. Editorial: Diabetes and Obesity Effects on Lung Function.

9. Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma.

10. Targeted silencing of TEM8 suppresses non‑small cell lung cancer tumor growth via the ERK/Bcl‑2 signaling pathway.